Logo image of BYON

BEYOND INC (BYON) Stock Fundamental Analysis

NYSE:BYON - US6903701018 - Common Stock

9.7 USD
+0.05 (+0.52%)
Last: 8/22/2025, 8:04:00 PM
9.72 USD
+0.02 (+0.21%)
After Hours: 8/22/2025, 8:04:00 PM
Fundamental Rating

1

BYON gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 124 industry peers in the Specialty Retail industry. BYON may be in some trouble as it scores bad on both profitability and health. BYON does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BYON has reported negative net income.
In the past year BYON has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: BYON reported negative net income in multiple years.
In multiple years BYON reported negative operating cash flow during the last 5 years.
BYON Yearly Net Income VS EBIT VS OCF VS FCFBYON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

BYON's Return On Assets of -56.28% is on the low side compared to the rest of the industry. BYON is outperformed by 95.16% of its industry peers.
With a Return On Equity value of -153.98%, BYON is not doing good in the industry: 75.81% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -56.28%
ROE -153.98%
ROIC N/A
ROA(3y)-39%
ROA(5y)-15.57%
ROE(3y)-83.49%
ROE(5y)-37.9%
ROIC(3y)N/A
ROIC(5y)N/A
BYON Yearly ROA, ROE, ROICBYON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

The Gross Margin of BYON (23.10%) is worse than 75.00% of its industry peers.
BYON's Gross Margin has been stable in the last couple of years.
BYON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y0.73%
BYON Yearly Profit, Operating, Gross MarginsBYON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

1

2. Health

2.1 Basic Checks

BYON does not have a ROIC to compare to the WACC, probably because it is not profitable.
BYON has more shares outstanding than it did 1 year ago.
BYON has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BYON is higher compared to a year ago.
BYON Yearly Shares OutstandingBYON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BYON Yearly Total Debt VS Total AssetsBYON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.25, we must say that BYON is in the distress zone and has some risk of bankruptcy.
BYON has a Altman-Z score of 0.25. This is amonst the worse of the industry: BYON underperforms 80.65% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that BYON is not too dependend on debt financing.
BYON has a Debt to Equity ratio of 0.14. This is in the better half of the industry: BYON outperforms 66.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 0.25
ROIC/WACCN/A
WACC9.3%
BYON Yearly LT Debt VS Equity VS FCFBYON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

BYON has a Current Ratio of 0.91. This is a bad value and indicates that BYON is not financially healthy enough and could expect problems in meeting its short term obligations.
BYON's Current ratio of 0.91 is on the low side compared to the rest of the industry. BYON is outperformed by 77.42% of its industry peers.
BYON has a Quick Ratio of 0.91. This is a bad value and indicates that BYON is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.87, BYON is doing good in the industry, outperforming 72.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.87
BYON Yearly Current Assets VS Current LiabilitesBYON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.89% over the past year.
BYON shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.63%.
BYON shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.56% yearly.
EPS 1Y (TTM)16.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.34%
Revenue 1Y (TTM)-26.63%
Revenue growth 3Y-20.31%
Revenue growth 5Y-0.56%
Sales Q2Q%-29.1%

3.2 Future

Based on estimates for the next years, BYON will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.46% on average per year.
Based on estimates for the next years, BYON will show a quite strong growth in Revenue. The Revenue will grow by 13.73% on average per year.
EPS Next Y77.84%
EPS Next 2Y36.79%
EPS Next 3Y23.39%
EPS Next 5Y17.46%
Revenue Next Year-26.42%
Revenue Next 2Y-9.4%
Revenue Next 3Y-0.88%
Revenue Next 5Y13.73%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BYON Yearly Revenue VS EstimatesBYON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
BYON Yearly EPS VS EstimatesBYON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BYON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BYON. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYON Price Earnings VS Forward Price EarningsBYON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BYON Per share dataBYON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as BYON's earnings are expected to grow with 23.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.79%
EPS Next 3Y23.39%

More info and screens

0

5. Dividend

5.1 Amount

BYON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEYOND INC

NYSE:BYON (8/22/2025, 8:04:00 PM)

After market: 9.72 +0.02 (+0.21%)

9.7

+0.05 (+0.52%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-28 2025-07-28/amc
Earnings (Next)10-22 2025-10-22/bmo
Inst Owners59.06%
Inst Owner ChangeN/A
Ins Owners1.57%
Ins Owner Change9.05%
Market Cap556.88M
Analysts74.29
Price Target11.12 (14.64%)
Short Float %12.69%
Short Ratio2.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.86%
Min EPS beat(2)21.2%
Max EPS beat(2)46.52%
EPS beat(4)2
Avg EPS beat(4)-33.62%
Min EPS beat(4)-121.07%
Max EPS beat(4)46.52%
EPS beat(8)3
Avg EPS beat(8)-34.81%
EPS beat(12)6
Avg EPS beat(12)-36.04%
EPS beat(16)9
Avg EPS beat(16)-27.97%
Revenue beat(2)1
Avg Revenue beat(2)-5.28%
Min Revenue beat(2)-21.15%
Max Revenue beat(2)10.58%
Revenue beat(4)1
Avg Revenue beat(4)-8.17%
Min Revenue beat(4)-21.15%
Max Revenue beat(4)10.58%
Revenue beat(8)3
Avg Revenue beat(8)-4.11%
Revenue beat(12)5
Avg Revenue beat(12)-3.62%
Revenue beat(16)6
Avg Revenue beat(16)0.87%
PT rev (1m)51.39%
PT rev (3m)-9.17%
EPS NQ rev (1m)16.67%
EPS NQ rev (3m)23.95%
EPS NY rev (1m)20.2%
EPS NY rev (3m)20.2%
Revenue NQ rev (1m)-1.18%
Revenue NQ rev (3m)-19.61%
Revenue NY rev (1m)1.92%
Revenue NY rev (3m)1.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.49
P/FCF N/A
P/OCF N/A
P/B 4.26
P/tB 6.04
EV/EBITDA N/A
EPS(TTM)-3.64
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-1.97
FCFYN/A
OCF(TTM)-1.72
OCFYN/A
SpS19.66
BVpS2.28
TBVpS1.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.28%
ROE -153.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.1%
FCFM N/A
ROA(3y)-39%
ROA(5y)-15.57%
ROE(3y)-83.49%
ROE(5y)-37.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y0.73%
F-Score5
Asset Turnover3.15
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 73.64%
Cap/Sales 1.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.87
Altman-Z 0.25
F-Score5
WACC9.3%
ROIC/WACCN/A
Cap/Depr(3y)142.46%
Cap/Depr(5y)112.5%
Cap/Sales(3y)1.7%
Cap/Sales(5y)1.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.34%
EPS Next Y77.84%
EPS Next 2Y36.79%
EPS Next 3Y23.39%
EPS Next 5Y17.46%
Revenue 1Y (TTM)-26.63%
Revenue growth 3Y-20.31%
Revenue growth 5Y-0.56%
Sales Q2Q%-29.1%
Revenue Next Year-26.42%
Revenue Next 2Y-9.4%
Revenue Next 3Y-0.88%
Revenue Next 5Y13.73%
EBIT growth 1Y39.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.31%
EBIT Next 3Y27.11%
EBIT Next 5Y20.13%
FCF growth 1Y-92.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-534.55%
OCF growth 3YN/A
OCF growth 5YN/A